GAO Recommends US Agencies Develop Performance Metrics to Gauge Effectiveness of Efforts to Combat Synthetic Opioid Threat – APhA submits compounding comments to FDA.

4Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

GAO Recommends US Agencies Develop Performance Metrics to Gauge Effectiveness of Efforts to Combat Synthetic Opioid Threat – APhA submits compounding comments to FDA. – (866) 348-2889.

Many United States agencies’ documented that opioid response strategies lack outcome-oriented performance measures, indicates a new report by the US Government Accountability Office (GAO). Without specific outcome-oriented performance measures, federal agencies will not be able to truly assess whether their respective investments and efforts are helping them to limit the availability of and better respond to the synthetic opioid threat, states the GAO report Illicit Opioids: While Greater Attention Given to Combating Synthetic Opioids, Agencies Need to Better Assess their Efforts.

In response to a request from members of Congress to review US agency efforts to combat illicit synthetic opioids, GAO reviewed documents that described agencies’ international coordination efforts, domestic opioid reduction strategies and prevention and treatment approaches, and interviewed international and federal agency officials engaged in drug control policy. GAO also interviewed state and local law enforcement and public health officials in seven states that were selected in part for their high rates of overdose deaths.

CLICK HERE FOR CONTINUE READING

This entry was posted in Pharmacist and tagged , , , . Bookmark the permalink.

Comments are closed.